Topics
High-grade gliomas | Treatment | Clinical trials | Camrelizumab
Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials > Camrelizumab
Chen Z, Guo C, Yang Q, Lin F, Hu W, Xi S, Zhang J, Jiang X, Li D,
Chen Y, Ke C, Zhou J, Zhou Z, Ceng S.
AB048.
Evidence of effectiveness of neoadjuvant camrelizumab and apatinib
in patients with recurrent high-grade gliomas.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB048. doi:
10.21037/cco-24-ab048. PMID:
39295366. Interventional study. ˍ